The largest database of trusted experimental protocols

Psin ef2 sox2 pur

Manufactured by Addgene
Sourced in United States

The PSin-EF2-SOX2-Pur is a plasmid construct that contains the SOX2 gene under the control of the EF2 promoter, along with a puromycin resistance marker. This plasmid can be used for the expression of the SOX2 transcription factor in cell culture experiments.

Automatically generated - may contain errors

4 protocols using psin ef2 sox2 pur

1

Conditional Depletion and Overexpression of SOX2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conditional depletion of SOX2 was achieved using a doxycycline-inducible system obtained from Addgene (Cambridge, MA, USA) (Tet-pLKO-puro-SOX2; plasmid 47540) [50 (link)]. In addition, we also used a PLKO.1 lentivirus shRNA vector targeted against SOX2 (TRCN0000085748) together with the corresponding empty shRNA vector as a negative control (Dharmacon Lafayette, CO, USA). As an alternative method to knockdown SOX2 expression we used a specific siRNA (Supplementary Information). The lentiviral constructions to overexpress SOX2 (pSin-EF2-SOX2-Pur; addgene plasmid 16577) or GFP (used as a control) (pSin-EF2-GFP-Pur) cDNAs were kindly donated by Maria dM. Vivanco (CIC bioGUNE, Derio, Spain). Lentiviral reporter systems in which a composite SOX2/OCT4 response element (SORE6) coupled to a minimal cytomegalovirus (mCMV) drive the expression of GFP (SORE6-mCMVp-dsCopGFP-Puro) and its corresponding control lacking SORE6 (mCMVp-dsCopGFP-Puro) were previously generated and characterized [29 (link)] and were kindly donated by Dr. L.M. Wakefield (National Cancer Institute, Bethesda, MD, USA). Generation of lentiviral particles were performed as previously described [34 (link)]. Transduced cells were positively selected through a treatment with puromycin 30 mg/mL for 6 days. To achieve an inducible expression of SOX2 shRNA in vitro, cells were treated with 2 μg/mL of doxycycline (Sigma).
+ Open protocol
+ Expand
2

Lentiviral Vectors for RPPH1 and TUBB3 Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pfu Ultra II Fusion HS DNA Polymerase (Stratagene, Agilent Technologies) was used to amplify the cDNA encoding RPPH1 or TUBB3 and then the cDNA was cloned into lentiviral expression vector pSin-EF2-Pur reformed from pSin-EF2-Sox2-Pur (Addgene, Cambridge, MA, USA). The oligonucleotides to suppress RPPH1 or TUBB3 expression were designed by RiboBio (Guangzhou, China). Then they were cloned into lentiviral expression vector pLKO.1-Pur (Addgene, Cambridge, MA, USA). The plasmids were verified by sequencing. Empty vector pSin-EF2-Pur and vector pLKO.1-Pur carrying a scrambled shRNA served as a control. 293T cells were incubated with the vectors described above, psPAX2 and pMD2G (Addgene) according to the manufacturer’s instructions. The supernatant containing infectious lentivirus was filtered through 0.22 μm PVDF filters after harvesting at 24 h post transfection and then added into the plate to infect SW620 and HCT8 cells. Infection efficiency was confirmed by qRT-PCR. The methods for transfection and lentiviral infection were described in a previous study43 (link). The oligonucleotide sequences for vector construction are listed in Supplementary Table 5.
+ Open protocol
+ Expand
3

Lentiviral Transduction of Sox2 in TSCC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human full-length Sox2 cDNA was cloned into pSin-EF2-Sox2-Pur (plasmid no. 16577; Addgene, Inc., Cambridge, MA, USA). Using co-transfection of plasmid DNA with lentivector plus helper plasmids (pRSV-REV, pMDLg-pRRE and pMD2.G) (isoconcentration), transfected into 293T cells occurred using Lipofectamine® 2000 (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). In order to improve the transfection efficiency, 6 μg/ml polybrene was added in the culture medium incubated with TSCC cells and lentivirus. Stable Sox2-overexpressing TSCC cells were purified using the antibiotic puromycin.
+ Open protocol
+ Expand
4

Lentiviral Manipulation of CAMK2A and SOX2

Check if the same lab product or an alternative is used in the 5 most similar protocols
ShRNA targeting human CAMK2A and EZH2 were from Sigma-Aldrich (St Louis, MO). ShRNA targeting SOX2 a and b (26353, 26352), the negative control vector pLKO.1-puro (1864), the envelope vector pMD2.G (12259) and packaging vector psPAX2 (12260) were from Addgene (Cambrige, MA; http://www.addgene.org). Human full length CAMK2A was cloned into PCDH-CMV-MCS-EF1-COPGFP vector (SBI, Mountain View, CA) for stable CAMK2A overexpression. pSin-EF2-SOX2-Pur (16577, Addgene) was used for stable SOX2 overexpression. Lentiviral production and infection were performed as previously described10 . Stable cells were either selected by treating puromycin (2 µg/ml, Sigma-Aldrich) or by FACS using BD Aria (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!